Literature DB >> 19485944

Immunohistochemical expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in invasive breast carcinoma.

Suada Kuskunović1, Svjetlana Radović, Mirsad Dorić, Ajna Hukić, Mirsad Babić, Ivana Tomić, Ivan Selak.   

Abstract

Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a natural inhibitor of matrix metalloproteinases (MMPs). Aim of this study was to assess the immunohistochemical expression of TIMP-1 in invasive breast carcinomas, and to examine its association with classical clinico-pathological parameters, oestrogen receptor, progesterone receptor and Her-2/neu protein expression. Immunohistochemistry was used to determine the expression of TIMP-1 on 38 paraffin-embedded breast tissue specimens - 18 with invasive ductal carcinoma, 10 with invasive lobular carcinoma, and 10 specimens from patients with fibrocystic breast disease. TIMP-1 protein was immunodetected in the carcinoma cells, fibroblasts and inflammatory cells of the stroma in 92,9%, 65,8%, and 65,8% of cases, respectively. TIMP-1 protein expression in carcinoma cells showed positive correlation with TIMP-1 protein expression in peritumoural fibroblasts (p=0,010). Positive peritumoural fibroblast TIMP-1 expression was associated with histological tumour type with higher frequency in ductal carcinomas (p=0,023). Negative association was found between TIMP-1 protein expression in carcinoma cells and HER-2/neu nuclear staining (p=0,005). TIMP-1 may be particularly useful as a predictive marker in breast carcinoma when evaluated along with HER-2/neu protein being a promising indicator of favourable prognosis in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19485944      PMCID: PMC5638216          DOI: 10.17305/bjbms.2009.2831

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  12 in total

1.  Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.

Authors:  P O-Charoenrat; P H Rhys-Evans; S A Eccles
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-07

2.  Characterization of anti-TIMP-1 monoclonal antibodies for immunohistochemical localization in formalin-fixed, paraffin-embedded tissue.

Authors:  Irene Vejgaard Sorensen; Claus Fenger; Henrik Winther; Niels T Foged; Ulrik Lademann; Nils Brünner; Pernille A Usher
Journal:  J Histochem Cytochem       Date:  2006-03-03       Impact factor: 2.479

3.  Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer.

Authors:  Anne-Sofie Schrohl; Ib Jarle Christensen; Anders N Pedersen; Vibeke Jensen; Henning Mouridsen; Gillian Murphy; John A Foekens; Nils Brunner; Mads Nikolaj Holten-Andersen
Journal:  Mol Cell Proteomics       Date:  2003-04-02       Impact factor: 5.911

Review 4.  Matrix metalloproteinases in tumor invasion.

Authors:  N Johansson; M Ahonen; V M Kähäri
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

Review 5.  Tissue inhibitor of metalloproteinases-1 in breast cancer.

Authors:  S Ø Würtz; A-S Schrohl; N Møller Sørensen; U Lademann; I J Christensen; H Mouridsen; N Brünner
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

6.  High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer.

Authors:  K McCarthy; T Maguire; G McGreal; E McDermott; N O'Higgins; M J Duffy
Journal:  Int J Cancer       Date:  1999-02-19       Impact factor: 7.396

7.  Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis.

Authors:  Lydia Nakopoulou; Ioanna Giannopoulou; Kalliopi Stefanaki; Effie Panayotopoulou; Ioanna Tsirmpa; Paraskevi Alexandrou; John Mavrommatis; Sophia Katsarou; Panagiotis Davaris
Journal:  J Pathol       Date:  2002-07       Impact factor: 7.996

Review 8.  TIMP-1 as a tumor marker in breast cancer--an update.

Authors:  Sidse O Würtz; Anne-Sofie Schrohl; Henning Mouridsen; Nils Brünner
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

9.  The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells.

Authors:  L Nakopoulou; I Giannopoulou; A Ch Lazaris; P Alexandrou; I Tsirmpa; S Markaki; E Panayotopoulou; A Keramopoulos
Journal:  APMIS       Date:  2003-11       Impact factor: 3.205

10.  Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.

Authors:  L O González; I Pidal; S Junquera; M D Corte; J Vázquez; J C Rodríguez; M L Lamelas; A M Merino; J L García-Muñiz; F J Vizoso
Journal:  Br J Cancer       Date:  2007-09-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.